FDA
-
Bivacor wins FDA breakthrough nod for titanium total artificial heart
The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically suitable for longer-term use.
By Nick Paul Taylor • June 2, 2025 -
Boston Scientific ends TAVR sales; J&J shares Monarch robot data
Boston Scientific said it would halt worldwide sales of its Acurate devices due to “increased clinical and regulatory requirements.”
By Elise Reuter • May 28, 2025 -
FDA finds Chinese lab copied or falsified data, endangering patients
The FDA said the findings raise doubts about the reliability and viability of premarket submissions based on the company’s data.
By Nick Paul Taylor • May 28, 2025 -
BD recalls esophagogastric tubes linked to 2 serious injuries, 1 death
A problem when preparing the devices for use can delay diagnosis or treatment, leading BD to update its instructions.
By Nick Paul Taylor • May 27, 2025 -
Stryker wins FDA clearance for minimally invasive back pain treatment
The company will compete with a device Boston Scientific acquired for $850 million.
By Nick Paul Taylor • May 22, 2025 -
FDA sets stricter approval standards for COVID vaccines
The agency will now require randomized, controlled data before approving new COVID shots for healthy children and adults, Commissioner Martin Makary and top vaccine official Vinay Prasad wrote in NEJM.
By Delilah Alvarado • May 20, 2025 -
FDA clears first blood test to aid Alzheimer’s diagnosis
The FDA cleared the test for the early detection of amyloid plaques associated with Alzheimer’s in people aged 55 years and older with signs and symptoms of the disease.
By Nick Paul Taylor • May 19, 2025 -
Retrieved from Teal Health on May 13, 2025
Teal wins FDA approval for at-home cervical cancer screening device
The company plans to start shipping the device in June, starting in California and then expanding nationwide.
By Nick Paul Taylor • May 13, 2025 -
FDA, aiming to speed scientific reviews, names chief AI officer
Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA scientists spend less time on repetitive tasks.
By Susan Kelly • May 9, 2025 -
AdvaMed calls for ‘zero for zero’ medtech tariffs between US and UK
AdvaMed and its British counterpart called for urgent action to ensure the situation “does not devolve into a crisis.”
By Nick Paul Taylor • May 7, 2025 -
HHS overhaul
State attorneys general sue over ‘unconstitutional’ HHS restructuring
The lawsuit alleges the Trump administration overstepped its authority in reshaping the federal health department and asked the court to reinstate workers laid off last month.
By Susanna Vogel • May 7, 2025 -
HHS overhaul
RFK’s FDA layoffs could slow safety communications, experts warn
The mass cuts, which included communications staff, could slow public notices on medical device recalls and other safety alerts.
By Elise Reuter • May 6, 2025 -
Edwards gains expanded TAVR label for asymptomatic patients
The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.
By Susan Kelly • May 5, 2025 -
Tracker
Trump policies are upending healthcare. Track the effect on the medtech industry here.
AdvaMed’s CEO praised comments from FDA chief Martin Makary about Medicare covering breakthrough devices more quickly. Elsewhere, a court halted most of Trump’s tariff plans, but an appeals court blocked the ruling.
By MedTech Dive Staff • Updated May 30, 2025 -
Medtronic wins FDA approval for defibrillation lead
Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, according to Medtronic.
By Nick Paul Taylor • Updated May 5, 2025 -
ICU Medical receives FDA warning letter over infusion pumps
Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.
By Nick Paul Taylor • April 29, 2025 -
Medtronic submits Hugo soft tissue robot for FDA approval
William Blair analyst Brandon Vazquez said 2025 could be the first year market leader Intuitive Surgical will face meaningful U.S. competition.
By Susan Kelly • April 28, 2025 -
Medtronic seeks FDA nod for insulin pump, furthering Abbott collab
Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by Abbott.
By Elise Reuter • April 24, 2025 -
Device developers advance AI plans despite Trump uncertainty
Trump administration policies have raised questions about how the FDA will regulate AI in medical devices. AdvaMed board members think the agency should keep its leading role.
By Elise Reuter • April 24, 2025 -
FDA issues early alert for BD catheters due to leaks
BD recalled certain intravascular catheters tied to reports of 10 serious injuries after finding an increase in cracks from “material fatigue.”
By Susan Kelly • April 21, 2025 -
Precision Neuroscience receives FDA clearance for brain implant
The electrode array, which can be implanted for 30 days to map brain activity, is a component of Precision Neuroscience’s planned brain-computer interface system.
By Elise Reuter • April 21, 2025 -
Medtronic gets FDA approval to use Simplera Sync glucose sensor with insulin pumps
The updated device allows users to pair the sensor with Medtronic’s insulin pumps, and is expected to grow the company’s diabetes business.
By Elise Reuter • April 21, 2025 -
Deep Dive // HHS overhaul
HHS layoffs may be illegal, legal experts say
The federal health department sidestepped normal procedures as it laid off 10,000 employees, according to sources. One union has already filed an internal complaint, while at least two law firms are exploring suits.
By Rebecca Pifer • April 21, 2025 -
Retrieved from Ceribell on April 17, 2025
Ceribell wins FDA nod for algorithm to detect pediatric seizures
The clearance adds another feature for Ceribell to leverage as it tries to persuade hospitals to switch from conventional EEG systems.
By Nick Paul Taylor • April 21, 2025 -
Makary seeks to limit industry’s role in FDA advisory panels
Commissioner Martin Makary said the agency would, whenever possible, restrict drug company employees from participating as industry representatives on advisory committees.
By Ned Pagliarulo • Updated April 18, 2025